EDGC, 1.7 Trillion Won Floods BW Public Offering, 'Successful Hit'
A large amount of funds poured into the general public subscription for the bonds with warrants (BW) of EDGC (Eone Diagnomics Genome Center), a precision medicine company specializing in genome analysis.
According to the final tally of EDGC's general subscription on the 10th, approximately KRW 1.7645 trillion was applied for the KRW 20 billion offering, recording a competition rate of 88.23 to 1.
The exercise price of the bonds with warrants is KRW 1,517. The annual interest rate of 3.00% refers to the coupon rate. The yield to put (YTP) and yield to maturity (YTM) are both 6.00% per annum. The warrant exercise period is from June 11, 2023, which is one month after the bond issuance date, until April 11, 2026, one month before maturity.
An EDGC official stated, "We analyze that the improved overseas performance and expectations for new businesses such as new drug development and AI-based distributed genome social network services led to the success of the bonds with warrants subscription."
He added, "Through public offering fundraising, we will continue sustainable management innovation by reducing debt through loan repayment, improving sales profit margins, and cutting selling and administrative expenses."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
EDGC, listed on the KOSDAQ market in 2018, is a leading domestic bio healthcare company. Using cutting-edge genomics technology, it is dedicated to prenatal and newborn screening, cancer screening, and diagnostics and therapeutic development in neurological and personal genetics fields.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.